Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Ocular complications in a young pediatric population following bone marrow transplantation.

Hoehn ME, Calderwood J, Gannon E, Cook B, Rochester R, Hartford C, Triplett B, Sunkara A, Kang G, Walton RC.

J AAPOS. 2018 Apr;22(2):102-106.e1. doi: 10.1016/j.jaapos.2017.10.010. Epub 2018 Jan 5.

PMID:
29309836
2.

Alert dwell time: introduction of a measure to evaluate interruptive clinical decision support alerts.

McDaniel RB, Burlison JD, Baker DK, Hasan M, Robertson J, Hartford C, Howard SC, Sablauer A, Hoffman JM.

J Am Med Inform Assoc. 2016 Apr;23(e1):e138-41. doi: 10.1093/jamia/ocv144. Epub 2015 Oct 24.

3.

Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies.

Triplett BM, Shook DR, Eldridge P, Li Y, Kang G, Dallas M, Hartford C, Srinivasan A, Chan WK, Suwannasaen D, Inaba H, Merchant TE, Pui CH, Leung W.

Bone Marrow Transplant. 2015 Jul;50(7):1012. doi: 10.1038/bmt.2015.139. No abstract available.

PMID:
26130176
4.

Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia.

Topka S, Vijai J, Walsh MF, Jacobs L, Maria A, Villano D, Gaddam P, Wu G, McGee RB, Quinn E, Inaba H, Hartford C, Pui CH, Pappo A, Edmonson M, Zhang MY, Stepensky P, Steinherz P, Schrader K, Lincoln A, Bussel J, Lipkin SM, Goldgur Y, Harit M, Stadler ZK, Mullighan C, Weintraub M, Shimamura A, Zhang J, Downing JR, Nichols KE, Offit K.

PLoS Genet. 2015 Jun 23;11(6):e1005262. doi: 10.1371/journal.pgen.1005262. eCollection 2015 Jun.

5.

Genome-wide single-nucleotide polymorphism analysis revealed SUFU suppression of acute graft-versus-host disease through downregulation of HLA-DR expression in recipient dendritic cells.

Bari R, Hartford C, Chan WK, Vong Q, Li Y, Gan K, Zhou Y, Cheng C, Kang G, Shurtleff S, Turner V, Pui CH, Downing JR, Leung W.

Sci Rep. 2015 Jun 11;5:11098. doi: 10.1038/srep11098.

6.

SVSI: fast and powerful set-valued system identification approach to identifying rare variants in sequencing studies for ordered categorical traits.

Bi W, Kang G, Zhao Y, Cui Y, Yan S, Li Y, Cheng C, Pounds SB, Borowitz MJ, Relling MV, Yang JJ, Liu Z, Pui CH, Hunger SP, Hartford CM, Leung W, Zhang JF.

Ann Hum Genet. 2015 Jul;79(4):294-309. doi: 10.1111/ahg.12117. Epub 2015 May 11.

7.

Natural killer cell therapy in children with relapsed leukemia.

Rubnitz JE, Inaba H, Kang G, Gan K, Hartford C, Triplett BM, Dallas M, Shook D, Gruber T, Pui CH, Leung W.

Pediatr Blood Cancer. 2015 Aug;62(8):1468-72. doi: 10.1002/pbc.25555. Epub 2015 Apr 30.

8.

Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies.

Triplett BM, Shook DR, Eldridge P, Li Y, Kang G, Dallas M, Hartford C, Srinivasan A, Chan WK, Suwannasaen D, Inaba H, Merchant TE, Pui CH, Leung W.

Bone Marrow Transplant. 2015 Jul;50(7):968-77. doi: 10.1038/bmt.2014.324. Epub 2015 Feb 9. Erratum in: Bone Marrow Transplant. 2015 Jul;50(7):1012.

9.

Retracted: IL-37 reduces inflammatory response after cerebral ischemia and reperfusion injury through down-regulation of pro-inflammatory cytokines.

Patel FJ, Volkmann DT, Taylor GW, Hansson MA, Anderson JF, Zhou Y, Scoazec LM, Hartford CV, Hainz DL.

Cytokine. 2014 Oct;69(2):234-9. doi: 10.1016/j.cyto.2014.06.011. Epub 2014 Jul 8.

PMID:
25010391
10.

Phase I study of the safety and pharmacokinetics of plerixafor in children undergoing a second allogeneic hematopoietic stem cell transplantation for relapsed or refractory leukemia.

Srinivasan A, Panetta JC, Cross SJ, Pillai A, Triplett BM, Shook DR, Dallas MH, Hartford C, Sunkara A, Kang G, Jacobsen J, Choi J, Leung W.

Biol Blood Marrow Transplant. 2014 Aug;20(8):1224-8. doi: 10.1016/j.bbmt.2014.04.020. Epub 2014 Apr 23.

11.

RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients.

Cao X, Mitra AK, Pounds S, Crews KR, Gandhi V, Plunkett W, Dolan ME, Hartford C, Raimondi S, Campana D, Downing J, Rubnitz JE, Ribeiro RC, Lamba JK.

Pharmacogenomics. 2013 Sep;14(12):1449-66. doi: 10.2217/pgs.13.131.

12.

Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia.

Rujkijyanont P, Morris C, Kang G, Gan K, Hartford C, Triplett B, Dallas M, Srinivasan A, Shook D, Pillai A, Pui CH, Leung W.

Blood Cancer J. 2013 Aug 30;3:e137. doi: 10.1038/bcj.2013.39.

13.

Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients.

Gamazon ER, Lamba JK, Pounds S, Stark AL, Wheeler HE, Cao X, Im HK, Mitra AK, Rubnitz JE, Ribeiro RC, Raimondi S, Campana D, Crews KR, Wong SS, Welsh M, Hulur I, Gorsic L, Hartford CM, Zhang W, Cox NJ, Dolan ME.

Blood. 2013 May 23;121(21):4366-76. doi: 10.1182/blood-2012-10-464149. Epub 2013 Mar 28.

14.

Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease.

Dallas MH, Triplett B, Shook DR, Hartford C, Srinivasan A, Laver J, Ware R, Leung W.

Biol Blood Marrow Transplant. 2013 May;19(5):820-30. doi: 10.1016/j.bbmt.2013.02.010. Epub 2013 Feb 14.

15.

Successful allogeneic hematopoietic cell engraftment after a minimal conditioning regimen in children with relapsed or refractory solid tumors.

Shook DR, Triplett BM, Srinivasan A, Hartford C, Dallas MH, Pillai A, Laver J, Leung W.

Biol Blood Marrow Transplant. 2013 Feb;19(2):291-7. doi: 10.1016/j.bbmt.2012.10.001. Epub 2012 Oct 9.

16.

Longitudinal changes in body mass and composition in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem-cell transplantation.

Inaba H, Yang J, Kaste SC, Hartford CM, Motosue MS, Chemaitilly W, Triplett BM, Shook DR, Pui CH, Leung W.

J Clin Oncol. 2012 Nov 10;30(32):3991-7. doi: 10.1200/JCO.2011.40.0457. Epub 2012 Oct 1.

17.

Detection of respiratory viruses in asymptomatic children undergoing allogeneic hematopoietic cell transplantation.

Srinivasan A, Flynn P, Gu Z, Hartford C, Lovins R, Sunkara A, Srivastava DK, Leung W, Hayden RT.

Pediatr Blood Cancer. 2013 Jan;60(1):149-51. doi: 10.1002/pbc.24314. Epub 2012 Sep 14.

18.

Phase I studies of sirolimus alone or in combination with pharmacokinetic modulators in advanced cancer patients.

Cohen EE, Wu K, Hartford C, Kocherginsky M, Eaton KN, Zha Y, Nallari A, Maitland ML, Fox-Kay K, Moshier K, House L, Ramirez J, Undevia SD, Fleming GF, Gajewski TF, Ratain MJ.

Clin Cancer Res. 2012 Sep 1;18(17):4785-93. doi: 10.1158/1078-0432.CCR-12-0110. Epub 2012 Aug 7.

19.

Effects of conditioning regimens and T cell depletion in hematopoietic cell transplantation for primary immune deficiency.

Triplett BM, Wang C, Yang J, Dallas M, Hartford C, Howard V, Pillai A, Shook D, Srinivasan A, Laver J, Leung W.

Biol Blood Marrow Transplant. 2012 Dec;18(12):1911-20. doi: 10.1016/j.bbmt.2012.07.014. Epub 2012 Jul 27.

20.

Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia.

Leung W, Pui CH, Coustan-Smith E, Yang J, Pei D, Gan K, Srinivasan A, Hartford C, Triplett BM, Dallas M, Pillai A, Shook D, Rubnitz JE, Sandlund JT, Jeha S, Inaba H, Ribeiro RC, Handgretinger R, Laver JH, Campana D.

Blood. 2012 Jul 12;120(2):468-72. doi: 10.1182/blood-2012-02-409813. Epub 2012 Apr 19.

21.

Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantation.

Inaba H, Hartford CM, Pei D, Posner MJ, Yang J, Hayden RT, Srinivasan A, Triplett BM, McCulllers JA, Pui CH, Leung W.

Br J Haematol. 2012 Jan;156(1):109-17. doi: 10.1111/j.1365-2141.2011.08913.x. Epub 2011 Oct 24.

22.

Favorable preliminary results using TLI/ATG-based immunomodulatory conditioning for matched unrelated donor allogeneic hematopoietic stem cell transplantation in pediatric severe aplastic anemia.

Pillai A, Hartford C, Wang C, Pei D, Yang J, Srinivasan A, Triplett B, Dallas M, Leung W.

Pediatr Transplant. 2011 Sep;15(6):628-34. doi: 10.1111/j.1399-3046.2011.01542.x. Epub 2011 Jul 15.

23.

Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia.

Mitra AK, Crews KR, Pounds S, Cao X, Feldberg T, Ghodke Y, Gandhi V, Plunkett W, Dolan ME, Hartford C, Raimondi S, Campana D, Downing J, Rubnitz JE, Ribeiro RC, Lamba JK.

J Pharmacol Exp Ther. 2011 Oct;339(1):9-23. doi: 10.1124/jpet.111.182873. Epub 2011 Jun 28.

24.

High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia.

Leung W, Campana D, Yang J, Pei D, Coustan-Smith E, Gan K, Rubnitz JE, Sandlund JT, Ribeiro RC, Srinivasan A, Hartford C, Triplett BM, Dallas M, Pillai A, Handgretinger R, Laver JH, Pui CH.

Blood. 2011 Jul 14;118(2):223-30. doi: 10.1182/blood-2011-01-333070. Epub 2011 May 25.

25.

Clinical pharmacology in the adolescent oncology patient.

Veal GJ, Hartford CM, Stewart CF.

J Clin Oncol. 2010 Nov 10;28(32):4790-9. doi: 10.1200/JCO.2010.28.3473. Epub 2010 May 3. Review.

26.

Pulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantation.

Inaba H, Yang J, Pan J, Stokes DC, Krasin MJ, Srinivasan A, Hartford CM, Pui CH, Leung W.

Cancer. 2010 Apr 15;116(8):2020-30. doi: 10.1002/cncr.24897.

27.

A phase I trial to determine the safety, tolerability, and maximum tolerated dose of deforolimus in patients with advanced malignancies.

Hartford CM, Desai AA, Janisch L, Karrison T, Rivera VM, Berk L, Loewy JW, Kindler H, Stadler WM, Knowles HL, Bedrosian C, Ratain MJ.

Clin Cancer Res. 2009 Feb 15;15(4):1428-34. doi: 10.1158/1078-0432.CCR-08-2076.

28.

Invited Critique.

Hartford CE.

J Burn Care Res. 2009 Jan 21. [Epub ahead of print] No abstract available.

PMID:
19165107
29.

A wound caused by a small alkaline cell (button battery) under a plaster cast: report of a case.

Moulton SL, Thaller LH, Hartford CE.

J Burn Care Res. 2009 Mar-Apr;30(2):355-7. doi: 10.1097/BCR.0b013e318198a734.

PMID:
19165098
30.

Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity.

Hartford CM, Duan S, Delaney SM, Mi S, Kistner EO, Lamba JK, Huang RS, Dolan ME.

Blood. 2009 Mar 5;113(10):2145-53. doi: 10.1182/blood-2008-05-154302. Epub 2008 Dec 24.

31.

Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans.

Huang RS, Duan S, Kistner EO, Hartford CM, Dolan ME.

Mol Cancer Ther. 2008 Sep;7(9):3038-46. doi: 10.1158/1535-7163.MCT-08-0248. Epub 2008 Sep 2.

32.

3 + 3 not equal to (Rolling) 6.

Hartford C, Volchenboum SL, Cohn SL.

J Clin Oncol. 2008 Jan 10;26(2):170-1. doi: 10.1200/JCO.2007.14.5052. No abstract available.

PMID:
18182656
33.

Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity.

Hartford CM, Dolan ME.

Pharmacogenomics. 2007 Sep;8(9):1159-68. Review.

34.

Fluid creep.

Hartford CE.

J Burn Care Res. 2007 Sep-Oct;28(5):770-2. No abstract available.

PMID:
17762389
35.

Rapamycin: something old, something new, sometimes borrowed and now renewed.

Hartford CM, Ratain MJ.

Clin Pharmacol Ther. 2007 Oct;82(4):381-8. Epub 2007 Aug 29. Review.

PMID:
17728765
36.

Genome scan implicates adhesion biological pathways in secondary leukemia.

Hartford C, Yang W, Cheng C, Fan Y, Liu W, TreviƱo L, Pounds S, Neale G, Raimondi SC, Bogni A, Dolan ME, Pui CH, Relling MV.

Leukemia. 2007 Oct;21(10):2128-36. Epub 2007 Aug 2.

PMID:
17673902
37.

Differential effects of targeted disruption of thiopurine methyltransferase on mercaptopurine and thioguanine pharmacodynamics.

Hartford C, Vasquez E, Schwab M, Edick MJ, Rehg JE, Grosveld G, Pui CH, Evans WE, Relling MV.

Cancer Res. 2007 May 15;67(10):4965-72.

38.

Pharmacovigilance during the pre-approval phases: an evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines.

Hartford CG, Petchel KS, Mickail H, Perez-Gutthann S, McHale M, Grana JM, Marquez P.

Drug Saf. 2006;29(8):657-73. Review.

PMID:
16872240
39.

Osteosarcoma among children aged 5 years or younger: the St. Jude Children's Research Hospital experience.

Hartford CM, Wodowski KS, Rao BN, Khoury JD, Neel MD, Daw NC.

J Pediatr Hematol Oncol. 2006 Jan;28(1):43-7.

PMID:
16394893
40.

The agreement between reaction-board measurements and kinematic estimation of adult male human whole body centre of mass location during running.

McKinon W, Hartford C, Di Zio L, van Schalkwyk J, Veliotes D, Hofmeyr A, Rogers G.

Physiol Meas. 2004 Dec;25(6):1339-54.

PMID:
15712714
41.

Primate pleuroesophageal tissue barrier frequency response and esophageal pressure waveform bandwidth in health and acute lung injury.

Hartford CG, van Schalkwyk JM, Rogers GG, Turner MJ.

Anesthesiology. 2000 Feb;92(2):550-8.

PMID:
10691244
42.

Invited commentary: surgical residency training.

Harken A, Hartford CE.

Surgery. 2000 Jan;127(1):12-3. No abstract available.

PMID:
10660752
43.

Building a balanced scorecard for a burn center.

Wachtel TL, Hartford CE, Hughes JA.

Burns. 1999 Aug;25(5):431-7.

PMID:
10439152
44.
45.

Sustained antihypertensive actions of a dual angiotensin-converting enzyme neutral endopeptidase inhibitor, sampatrilat, in black hypertensive subjects.

Norton GR, Woodiwiss AJ, Hartford C, Trifunovic B, Middlemost S, Lee A, Allen MJ.

Am J Hypertens. 1999 Jun;12(6):563-71.

PMID:
10371365
46.

Magma flow instability and cyclic activity at soufriere hills volcano, montserrat, british west indies

Voight B, Sparks RS, Miller AD, Stewart RC, Hoblitt RP, Clarke A, Ewart J, Aspinall WP, Baptie B, Calder ES, Cole P, Druitt TH, Hartford C, Herd RA, Jackson P, Lejeune AM, Lockhart AB, Loughlin SC, Luckett R, Lynch L, Norton GE, Robertson R, Watson IM, Watts R, Young SR.

Science. 1999 Feb 19;283(5405):1138-42.

47.

Frequency responses of infant air-balloon versus liquid-filled catheters for intra-esophageal pressure measurement.

Hartford CG, Turner MJ, van Schalkwyk JM, Rogers GG.

Pediatr Pulmonol. 1997 Nov;24(5):353-63.

PMID:
9407569
48.

Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats.

Norton GR, Tsotetsi J, Trifunovic B, Hartford C, Candy GP, Woodiwiss AJ.

Circulation. 1997 Sep 16;96(6):1991-8.

PMID:
9323091
49.

Correctly selecting a liquid-filled nasogastric infant feeding catheter to measure intraesophageal pressure.

Hartford CG, Rogers GG, Turner MJ.

Pediatr Pulmonol. 1997 May;23(5):362-9.

PMID:
9168510
50.

Predicting air-balloon and water-filled infant catheter frequency responses.

Hartford CG, van Schalkwyk JM, Rogers GG, Turner MJ.

IEEE Eng Med Biol Mag. 1997 May-Jun;16(3):27-33. No abstract available.

PMID:
9158982

Supplemental Content

Loading ...
Support Center